Abstract
A light-to-moderate wine consumption has been shown to provide several beneficial effects on the skeletal system, including reduced risk of bone mass loss and fractures. Wine is rich in phenolic compounds, strong phytoestrogens and natural antioxidants, to which bone protection is mainly attributed. The objective of this review was to give an overview of the exact mechanisms by which wine consumption is involved in bone protection. We found a great variety of in vitro research on the beneficial effects of isolated wine phenolics on the skeletal system, with a significant lack of evidence of their in vivo effects. In addition, we found almost no studies investigating how wine, a mixture of these phenolics dissolved in ethanol, affects the skeletal system. Our results warrant further research on this interesting topic.
Similar content being viewed by others
References
German JB, Walzem RL (2000) The health benefits of wine. Annu Rev Nutr 20:561–593
Vasanthi HR, Parameswari RP, DeLeiris J, Das DK (2012) Health benefits of wine and alcohol from neuroprotection to heart health. Front Biosci (Elite Ed) 4:1505–1512
Giacosa A, Adam-Blondon AF, Baer-Sinnott S, Barale R, Bavaresco L, Di Gaspero G, Dugo L, Ellison RC, Gerbi V, Gifford D, Janssens J, La Vecchia C, Negri E, Pezzotti M, Santi L, Santi L, Rondanelli M (2012) Alcohol and wine in relation to cancer and other diseases. Eur J Cancer Prev 21:103–108
Waterhouse AL (2002) Wine phenolics. Ann N Y Acad Sci 957:21–36
Deng XS, Deitrich RA (2007) Ethanol metabolism and effects: nitric oxide and its interaction. Curr Clin Pharmacol 2:145–153
Standridge JB, Zylstra RG, Adams SM (2004) Alcohol consumption: an overview of benefits and risks. South Med J 97:664–672
Jin M, Cai S, Guo J, Zhu Y, Li M, Yu Y, Zhang S, Chen K (2013) Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol 24:807–816
Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727–747
Muhlbauer RC, Lozano A, Reinli A, Wetli H (2003) Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 133:3592–3597
Hsu YL, Liang HL, Hung CH, Kuo PL (2009) Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway. Mol Nutr Food Res 53:1452–1461
Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663–673
Zhou H, Shang L, Li X, Zhang X, Gao G, Guo C, Chen B, Liu Q, Gong Y, Shao C (2009) Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp Cell Res 315:2953–2962
He X, Andersson G, Lindgren U, Li Y (2010) Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun 401:356–362
Dai Z, Li Y, Quarles LD, Song T, Pan W, Zhou H, Xiao Z (2007) Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 14:806–814
Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, Mizrak B (2005) Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 54:158–162
Habold C, Momken I, Ouadi A, Bekaert V, Brasse D (2011) Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension. J Bone Miner Metab 29:15–22
Zhang TJ, Zhang W, Bian LG, Liu SC, Yan J, Zong Y, Gui L, Lu D (2012) Protective effects and mechanisms of resveratrol on the rats suffering with osteoporosis. Acta Anatomica Sinica 43:679–684
Gehm BD, McAndrews JM, Chien PY, Jameson JL (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94:14138–14143
Bagchi D, Preuss HG, Bagchi M, Stohs SJ (2000) Phytoestrogen, resveratrol and women’s health (Review). Res Commun Pharmacol Toxicol 5:107–121
Ashby J, Tinwell H, Pennie W, Brooks AN, Lefevre PA, Beresford N, Sumpter JP (1999) Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 19:39–45
Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141:3657–3667
Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86:774–778
Chang JK, Hsu YL, Teng IC, Kuo PL (2006) Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur J Pharmacol 551:1–9
Piotrowska H, Kucinska M, Murias M (2012) Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res 750:60–82
Zoechling A, Reiter E, Eder R, Wendelin S, Liebner F, Jungbauer A (2009) The flavonoid kaempferol is responsible for the majority of estrogenic activity in red wine. Am J Enol Vitic 60:223–232
Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G (2005) Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin. Cell Tissue Res 319:383–393
Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M (2004) Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 92:285–295
Hsu YL, Chang JK, Tsai CH, Chien TT, Kuo PL (2007) Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem Pharmacol 73:504–514
Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P, Brazier M (2003) Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65:35–42
Choi EM, Hwang JK (2003) Effects of (+)-catechin on the function of osteoblastic cells. Biol Pharm Bull 26:523–526
Dou C, Li J, Kang F, Cao Z, Yang X, Jiang H, Yang B, Xiang J, Xu J, Dong S (2014) Dual effect of cyanidin on RANKL-induced differentiation and fusion of osteoclasts. J Cell Physiol. doi:10.1002/jcp.24916 (Epub ahead of print)
Moriwaki S, Suzuki K, Muramatsu M, Nomura A, Inoue F, Into T, Yoshiko Y, Niida S (2014) Delphinidin, one of the major anthocyanidins, prevents bone loss through the inhibition of excessive osteoclastogenesis in osteoporosis model mice. PLoS One 9:e97177
Folwarczna J, Zych M, Burczyk J, Trzeciak H, Trzeciak HI (2009) Effects of natural phenolic acids on the skeletal system of ovariectomized rats. Planta Med 75:1567–1572
Zych M, Folwarczna J, Pytlik M, Sliwiński L, Gołden MA, Burczyk J, Trzeciak HI (2010) Administration of caffeic acid worsened bone mechanical properties in female rats. Planta Med 76:407–411
Zych M, Folwarczna J, Trzeciak HI (2009) Natural phenolic acids may increase serum estradiol level in ovariectomized rats. Acta Biochim Pol 56:503–507
Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217–5221
Welch A, MacGregor A, Jennings A, Fairweather-Tait S, Spector T, Cassidy A (2012) Habitual flavonoid intakes are positively associated with bone mineral density in women. J Bone Miner Res 27:1872–1878
Venkat KK, Arora MM, Singh P, Desai M, Khatkhatay I (2009) Effect of alcohol consumption on bone mineral density and hormonal parameters in physically active male soldiers. Bone 45:449–454
Klein RF, Fausti KA, Carlos AS (1996) Ethanol inhibits human osteoblastic cell proliferation. Alcohol Clin Exp Res 20:572–578
Broulik PD, Vondrova J, Ruzicka P, Sedlacek R, Zima T (2010) The effect of chronic alcohol administration on bone mineral content and bone strength in male rats. Physiol Res 59:599–604
Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M, Gao X, Sholar JW (1996) Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA 276:1747–1751
Feskanich D, Korrick SA, Greenspan SL, Rosen HN, Colditz GA (1999) Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health 8:65–73
Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL (2000) Alcohol intake and bone metabolism in elderly women. Am J Clin Nutr 72:1206–1213
Ilich JZ, Brownbill RA, Tamborini L, Crncevic-Orlic Z (2002) To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? J Am Coll Nutr 21:536–544
Kubo JT, Stefanick ML, Robbins J, Wactawski-Wende J, Cullen MR, Freiberg M, Desai M (2013) Preference for wine is associated with lower hip fracture incidence in post-menopausal women. BMC Womens Health 13:36
Fairweather-Tait SJ, Skinner J, Guile GR, Cassidy A, Spector TD, MacGregor AJ (2011) Diet and bone mineral density study in postmenopausal women from the TwinsUK registry shows a negative association with a traditional English dietary pattern and a positive association with wine. Am J Clin Nutr 94:1371–1375
Marrone JA, Maddalozzo GF, Branscum AJ, Hardin K, Cialdella-Kam L, Philbrick KA, Breggia AC, Rosen CJ, Turner RT, Iwaniec UT (2012) Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause 19:974–979
Sommer I, Erkkila AT, Jarvinen R, Mursu J, Sirola J, Jurvelin JS, Kröger H, Tuppurainen M (2013) Alcohol consumption and bone mineral density in elderly women. Public Health Nutr 16:704–712
Ganry O, Baudoin C, Fardellone P (2000) Effect of alcohol intake on bone mineral density in elderly women: the EPIDOS study. Epidemiologie de l’Osteoporose. Am J Epidemiol 151:773–780
Holbrook TL, Barrett-Connor E (1993) A prospective study of alcohol consumption and bone mineral density. BMJ 306:1506–1509
Felson DT, Zhang Y, Hannan MT, Kannel WB, Kiel DP (1995) Alcohol intake and bone mineral density in elderly men and women. The Framingham study. Am J Epidemiol 142:485–492
Tucker KL, Chen H, Hannan MT, Cupples LA, Wilson PW, Felson D, Kiel DP (2002) Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 76:245–252
Wosje KS, Kalkwarf KJ (2007) Bone density in relation to alcohol intake among men and women in the United States. Osteoporosis Int 18:391–400
Mukamal KJ, Robbins JA, Cauley JA, Kern LM, Siscovick DS (2007) Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporos Int 18:593–602
Tucker KL, Jugdaohsingh R, Powell JJ, Qiao N, Hannan MT, Sripanyakorn S, Cupples LA, Kiel DP (2009) Effects of beer, wine, and liquor intakes on bone mineral density in older men and women. Am J Clin Nutr 89:1188–1196
Yin J, Winzenberg T, Quinn S, Giles G, Jones G (2011) Beverage-specific alcohol intake and bone loss in older men and women: a longitudinal study. Eur J Clin Nutr 65:526–532
Jin LH, Chang SJ, Koh SB, Kim KS, Lee TY, Ryu SY, Song JS, Park JK (2011) Association between alcohol consumption and bone strength in Korean adults: the Korean genomic rural cohort study. Metabolism 60:351–358
Kröger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis-a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55:1–7
Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79:155–165
McLernon DJ, Powell JJ, Jugdaohsingh R, Macdonald HM (2012) Do lifestyle choices explain the effect of alcohol on bone mineral density in women around menopause? Am J Clin Nutr 95:1261–1269
Keppler K, Humpf HU (2005) Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg Med Chem 13:5195–5205
Brizic I, Modun D, Vukovic J, Budimir D, Katalinic V, Boban M (2009) Differences in vasodilatory response to red wine in rat and guinea pig aorta. J Cardiovasc Pharmacol 53:116–120
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kutleša, Z., Budimir Mršić, D. Wine and bone health: a review. J Bone Miner Metab 34, 11–22 (2016). https://doi.org/10.1007/s00774-015-0660-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-015-0660-8